MedTrace Logo

THE EFFECT OF AROMATHERAPY FOOT BATHS ON CANCER PATIENTS

NCT07721168 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-07-22

No results posted yet for this study

Summary

The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question\[s\] it aims to answer are:

* Is an aromatherapy foot bath effective in reducing pain in cancer patients?
* Is an aromatherapy foot bath effective in improving sleep quality in cancer patients?
* Is an aromatherapy foot bath effective in reducing fatigue in cancer patients? The experimental group will receive a total of 5 sessions of aromatherapy foot baths, each lasting 20 minutes per day for 5 days, administered by the researcher. The control group will receive only routine care without any treatment. Before and after all treatments are completed, participants will be given and asked to complete the Hirai Cancer Fatigue Scale, the Pittsburgh Sleep Quality Index (PSQI), and the Numerical Pain Scale. The pain, fatigue, and sleep quality scores of the experimental and control groups will then be compared.

Conditions

  • Patients Diagnosed With Cancer

Interventions

OTHER

Aromatherapy

The experimental group will receive a foot bath treatment containing aromatherapy for 5 days administered by the researcher. A foot bath device will be used. Lavender essential oil will be added to the water as aromatherapy. Then, the researcher will administer a foot bath to the patient using this water.

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    lead OTHER

Principal Investigators

  • Semra Gündoğdu · Ankara Yildirim Beyazıt University

  • Erdal Ceylan · Ankara Yildirim Beyazıt University

  • Ahmet Özgen Yıldırım · Ankara Etlik City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2026-12-01
Completion
2026-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07721168 on ClinicalTrials.gov